OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

INCYTE DL-,001/  US45337C1027  /

Düsseldorf
24/01/2025  19:30:53 Chg. -0.04 Volume Bid20:04:02 Ask20:04:02 Market Capitalization Dividend Y. P/E Ratio
69.12EUR -0.06% 0
Turnover: 0.00		 -Bid Size: - -Ask Size: - 13.51 bill.EUR - -
Newsfile Corp 22/11/2024 SEC Announces Enforcement Results for Fiscal Year 2024
TeleTrader 19/11/2024 US opens sharply lower as geopolitics weigh on markets
GlobeNewswire 27/08/2024 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 27/08/2024 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 16/08/2024 China Medical System （00867） Released its 2024 Interim Results: Steady Increase in Revenue and Profi...
GlobeNewswire 06/08/2024 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
GlobeNewswire 01/08/2024 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire 30/07/2024 MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboratio...
Newsfile Corp 17/07/2024 Analysts Hunt for Undervalued Biotech Stocks
TeleTrader 09/07/2024 US closes mostly higher after Fed's chair testimony
GlobeNewswire 25/06/2024 China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...
GlobeNewswire 29/05/2024 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 28/05/2024 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
GlobeNewswire 09/05/2024 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire 08/05/2024 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 30/04/2024 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
GlobeNewswire 02/04/2024 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire 01/04/2024 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...
GlobeNewswire 28/02/2024 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire 09/01/2024 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
TeleTrader 12/12/2023 Wall Street closes higher after inflation report
GlobeNewswire 09/12/2023 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
GlobeNewswire 16/11/2023 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...
GlobeNewswire 02/11/2023 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
GlobeNewswire 23/10/2023 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...